Healthcare Industry News: Gilead
News Release - January 21, 2008
Gilead Announces Departure of Caroline Dorsa
John F. Milligan, PhD, Reassumes Role of Chief Financial OfficerFOSTER CITY, Calif.--(HSMN NewsFeed)--Gilead Sciences, Inc. (Nasdaq:GILD ) today announced that Caroline Dorsa has resigned from her position as Chief Financial Officer (CFO), a role she assumed in November 2007, to pursue another opportunity.
Gilead plans to initiate a search to identify a new CFO. In the interim, John F. Milligan, PhD, Gilead’s Chief Operating Officer, will reassume the additional responsibilities of CFO – a position he held from 2003 until 2007 – effective immediately.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead, please call the Gilead Public Affairs Department at 1-800-Gilead-5 (1-800-445-3235) or visit www.Gilead.com.
Source: Gilead Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!